Objective: The aim of the study was to investigate whether lithium chloride and medroxyprogesterone acetate can potentiate the cytotoxicity of imatinib mesylate in human endometrial cancer in vitro and the effect of midkine in these therapies. Methods: Imatinib mesylate (50 µM), lithium chloride (100 µM), medroxyprogesterone acetate (200 µM) and their combination were applied to monolayer and three dimensional cultures of human Ishikawa endometrial cancer for 72 hours. The cell prolife ra tion index, apoptotic index, caspase3 and midkine levels, cell cycle distributions in monolayer cultures and cell ultrastructure in spheroid cultures were evaluated. Results were statistically analyzed using the Student's ttest. Results: All drug applications inhibited cell proliferation (p<0.05), however the combination were the effective groups for 72 hours (p<0.05). Interestingly, although the loss of efficiency was seen higly seen every 24 hours at single applications, the inhibition rates of the combination groups were almost same for 72 hours. In concordance with these results, the apoptotic index, caspase3 levels (p<0.05), cell morphology and ultrastructure damages were much higher in the combination groups. Imatinib mesylate induced Sphase arrest, however other groups induced G0+G1phase arrest at 24 hours and all groups induced G0+G1 arrest at 72 hours (p<0.05). Imatinib mesylate and imatinib mesylate with medroxyprogesterone acetate induced highest decrease in midkine levels, respectively (p<0.05).
INTRODUCTION
Endometrial carcinoma is the most common type of uterine cancer and is a frequently seen gynecologic malignancy with breast cancer in developed countries. Patients with advanced or recurrent disease have poor prognosis sucha that it can be very hard to cure by surgery, conventional chemotherapy, radiation or a combination of these modalities. As some esti mate that the percent of women dying from endometrial car ci noma has increased by 227% over the past decade, there is a great need to develop novel targeted agents that can be used alone or in combination with current treatment strategies [1] .
Endometrial cancers are divided into two types (type I and type II) based on their biological, molecular and clinical para
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Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro 226 www.ejgo.org meters [2] . Eighty percent of cases consist of type I or those tumors of endometrioid histology. Previous studies showed that they arise from persistent unopposed estrogen stimulation and in addition, they are generally estrogen receptor and pro gesterone receptor positive. The underlying mechani sms can be listed as genetic alterations associated with these tumors include PTEN deletions or mutations (3683%), microsatellite instability (2040%), mutations of Kras (1530%) and gain of function mutations in βcatenin (2540%) [3, 4] .
Imatinib mesylate (IM) also called Gleevec or STI571 is a well known tyrosine kinase inhibitor that has been used as a "magic bullet" for the treatment of leukemia and gastrointestinal tu mours. IM inhibits the activity of a number of receptor tyro sine kinases as Abelson cytoplasmic tyrosine kinase (ABL), cKit, the plateletderived growth factor receptor, and epi dermal growth factor receptor (EGFR) [5] . Its success led the investiga tors to search its antineoplastic effects on other cancer types includ ing endometrial cancer [69] . Previous reports that studied IM demonstrated that endometrial cancers which expressed IM targets respond to IM treatment and in these reports they also mentioned that IM should be used in combination in order to make the treatment more efficient [6, 7] .
Lithium chloride (LiCl) has been used clinically since the 19th century to treat psychotic diseases as bipolar disorders, and its safety profile is well documented. Previous studies showed that LiCl also possess antineoplastic effects in a variety of can cers including colorectal cancer [10] , gastric cancer [11] , and neuroblastoma [12] . It was shown that antineoplastic action of LiCl primarily depends on the inhibition of glycogen syn thase kinase 3beta [13] .
Medroxyprogesterone acetate (MPA) is a synthetic, orally active derivative of the natural steroid hormone progesterone, widely used in contraception of women/men and in oncology, both in the endocrine treatment of hormonerelated cancers and as supportive therapy in the cachexia syndrome [14, 15] . MPA is the only approved drugs in Europe for the clinical treatment of cancerrelated anorexia/cachexia syndrome at the moment [16] . The anticontraceptive and antineoplastic effects of MPA are the results of the antiestrogenic action of MPA [17] . In the present study we focused on its antineoplastic effect. Wang et al. [18] proposed that Wnt/βcatenin signaling is activated by estrogen and inhibited by progesterone during the menstrual cycle. When this balanced is disrupted, the enhanced or unop posed estrogen signalling may lead to constitutive activation of Wnt/βcatenin signaling and this will trigger endometrial hyperplasia, which may develop further into endometrial can cer. In addition, the direct effect of enhanced or unopposed estrogen to nucleus through its receptor is the another reason for endometrial transformation to cancer. Midkine (MDK), a newly pronounced old molecule, is a heparin binding growth factor playing a central role in carcinogenesis as an antiapoptotic and angiogenic factor. High expression of MDK in various human tumors and the success gained after inhibition of MDK make it a promising target for specific thera pies [19] . It has been proven to be involved in tumorigenesis of neuroblastoma, astrocytoma and malignant peripheral nerve sheath tumors and an elevated MDK expression has been detected in tumors such as the colon, lung, pancreas, stomach, esopha geal tumors, hepatocellular carcinoma, and endometrial car cinoma [19] . It was shown that treatment of normal endome trial cells by 17beta oestradiol increased MDK levels [20] .
In the present study we investigated whether LiCl and MPA can potentiate the cytotoxicity of IM in treatment of endo metrial cancer and the effect of MDK in these therapies. We targeted to treat both multiple diseases and increase life qual ity at same time. This means LiCl may increase IM cytotoxicity, treat another type of cancer (primary and secondary) and psy chiatric disorder as bipolar disorder at the same time, on the another side different from LiCl, MPA can also treat cancer related cachexia/anorexia and prevent pregnancy. 
MATERIALS AND METHODS

Monolayer cell culture
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Ishikawa endometrium cells for 72 hours. The cell proliferation index, apoptotic index and cell cycle distributions by flow cytometry, morphology by scanning electron microscopy in monolayer cultures and cell ultrastructure by transmission electron microscopy (TEM) in three dimensional cultures were evaluated for 72 hours. Results were statistically analyzed us ing the Student's ttest.
Cell proliferation
The total cell number was counted by using an automated cell counter (NucleoCounter, ChemoMetec A/S, Allerod, Denmark). The starter kit which is com pa tible to cell counter and includes lysis buffer, stabilization buffer, nucleocasettes and software was used. Cells were harvested every 24 hours for 72 hours. Cells were pretreated with lysis and stabilization buffers to dissolve cell aggregates and lyse cell membranes. Pretreated cells were loaded to nucleocasettes which were coated with propidium iodid (PI) dye and their nuc lei was stained with PI. Nucleoca settes were placed in device for 3035 seconds to measure the PI fluorescence and then cell counts were analyzed with the software and recorded.
Apoptotic index
The apoptotic index was evaluated by using flow cytometric AnnexinVfluorescein isothiocyanate/propidium iodide (An nexinVFITC/PI) staining. Following the instruction manual of the kit (BD Pharmingen, San Diego, CA, USA), briefly, cells were washed twice with PBS and resuspended by binding buffer containing 0.01 M HEPES, 0.14 mM NaCl, and 2.5 mM CaCl 2 . A cell suspension (1×10 5 cells in 100 µL) in binding buffer was incubated with 5 µL of FITClabeled Annexin V (BD Pharmin gen) dye and PI for 15 minutes in the dark at room tempera ture. After incubation, the PI fluorescence and Annexin V were measured simultaneously in a BD FACS Calibur and analyzed with the instrument's operating software (CellQuest: BD Pharmingen). Data acquisition and analysis were undertaken with CellQuest and WinMDI programs.
Caspase-3 levels
Caspase3 levels in triplicate were analyzed using fluori metric kits (Sigma Aldrich, St. Louis, MO, USA). The caspase3 fluo rimetric assay is based on the hydrolysis of the peptide substrate acetylAspGluValAsp7amido4methylcoumarin (AcDEVDAMC) by caspase 3, resulting in the release of the fluorescent 7amino4methylcoumarin (AMC) moiety. 1×10 
Cell cycle distributions
The effects of drugs on the cell cycle were examined using a DNA analysis kit (BD Pharmingen) according to the manufac turer's instructions. Briefly, were induced at a cell density of 51 ×10 5 cells/ml in the presence of each drug applied separately and in combination for different time intervals (24 and 72 hours). Ishikawa cells were harvested, centrifuged, washed and resus pended in buffer (dimethylsulfoxide in sucrosesodium citrate) for 5 minutes at room temperature, respectively. A mixture of trypsin in spermine tetrahydrochloride detergent buffer was added and samples were incubated for 20 minutes at room temperature. After the addition of RNaseA and trypsin inhibi tor in spermine buffer, cells were incubated with propidium iodide, in dark, for 20 minutes at 4 o C. Finally, flow cytometric analysis was performed immediately using a Facscan flow cy to meter (FACS Diva, BeckmanDickinson, San Jose, CA, USA) and fluorescence intensity data were acquired using the in strument's operating software (CellQuest). The percentages of the analyzed cell population in G0/G1, S or G2/Mphases were determined by the Mod Fit cellcycle analysis program.
Transmission electron microscopy
Harvested spheroids were fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer and postfixed in 1% osmium tetraoxide in 0.1 M sodium cacodylate buffer for 1 hour at 4 o C. Cells were incubatedin 1% uranyl acetate for 1 hour at 4 o C, dehyd rated in a graded acetone series and embedded in Epon 812. Sam ples were cut using a rotating blade microtome (Leica, Heer brugg, Switzerland) and 70 nmthick sections were mounted on copper grids. Sections were subsequently stained with 5% uranyl acetate and counterstained with Reynold's lead citrate. Sections were examined with a JeolJem 1011 transmission electron microscope. Photographs were taken at several mag nifications.
Midkine levels
Cell culture supernatants were analyzed for midkine levels in triplicate using ELISA kits (PeproTech, Rocky Hill, NJ, USA). The lower detection limit of the assay was 150 pg/mL for midkine. Midkine levels were measured by an ELISA system in which polyclonal antihuman midkine was used as capture antibody (Peprotech). Detection was bybiotinylated polyclonal antihu man midkine antibody (PeproTech) followed by streptavidin 228 www.ejgo.org HRP (Sigma) and a TMB enzyme substrate system (Sigma). The reaction was stopped by 1 M H 2 SO 4 and readings were made at 450 nm by a spectrometer (M2, Molecular devices, Sunny vale, CA, USA).
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. Statistical analysis and determination of synergism SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA) and Excel 2007 were used for the statistical analysis. All results were statistically analyzed using the Student's ttest. Data were represented as mean±SE. A p<0.05 was considered significant. Synergy was determined as described previously [21] . Briefly, synergism was determined using the following formula: Combination index (CI): D1/(DX)1+D2/(DX)2 where D1 is tested concentra tion of IM used in combination with LiCl or MPA, D2 is the tested concentration of LiCl or MPA used in combination with IM, (DX)1 is the concentration of a singly applied IM and (DX)2 is the concentration of a singly applied LiCl or MPA. A CI value of 1 indicates an additive effect, a CI value <1 indicates a syn ergistic effect and a CI value >1 indicates an antagonist effect.
RESULTS
Cell proliferation
As shown in Fig. 1 , all drug treatments decreased cell num bers (p<0.05). Singly applied drugs lost their efficiency in a time de pendent manner, however the combination groups did not lose their efficiency and led to a high decrease in cell number for 72 hours (p<0.05). MPA and the combination of IM and MPA seemed to be the most efficient drug applica tions for 72 hours (p<0.05). Fig. 2 showed that all drug treatments increased the apop totic index (p<0.05). Apoptotic index of singly applied drugs decreased in a time dependent manner, but the apoptotic index induced by MPA was the highest (p<0.05). The combi nation groups induced higher apoptotic index than singly ap plied drugs and IM with MPA induced the highest apoptotic index (p<0.05).
Apoptotic index
Caspase-3 levels
Caspase3 levels in Fig. 3 showed that all drug treatments 
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increased apoptosis (p<0.05). The increase in caspase3 levels were determined both at single and combined drug applica tions (p<0.05). The highest increase were determined at the combination groups (p<0.05). MPA and IM with MPA induced the highest caspase3 levels (p<0.05).
Cell cycle distributions
LiCl, MPA and the combination groups led to G0+G1 arrest at 24 hour except for IM. IM induced Sphase arrest at this time interval. However, all drug applications induced G0+G1 arrest at 48 hours and 72 hours (Fig. 4) . Fig. 5 showed that all drug applications induced a decrease in MDK levels for 72 hours (p<0.05). Highest decrease was determined at IM combined with MPA and IM combined with LiCl, respectively for 72 hours (p<0.05). Among single applied drugs, IM induced highest decrease and the latter were MPA and then LiCl (p<0.05).
Midkine levels
TEM
According to the TEM results in Fig. 6 , the cells of the control group presented healthy morphology including intact cell mem brane with microvilli, cell junctions, intact nuclear membranes with the proportional spread euchromatin, the proportional distribution of nucleus and cytoplasm, mitochondria in a nor mal size with intact outer and inner cell membranes, cytoplas mic reticulums and ribosomes in a normal size. The intranucle ar channel formation and lipid vacuoles were determined in some cells of spheroids (Fig. 6A) . After IM was applied, disrup ted cell mebranes, apparent cell apoptosis was observed, i.e. chromatins aggregated around nuclear membrane, intact nu clear membrane, vacuoles with unknown content, cell rem nants were determined between intercellular area. Gaps were formed inside the spheroids due the loss of cell interrac tions (Fig. 6B ). LiCl applied spheroids showed that intact cell and nuclear membranes, the loss of cell to cell interactions, lytic cytoplasm with many vacuoles with unknown content and autophagic vacuoles, many lipid vacuoles (Fig. 6C) . The spheroids of the combination group IM with LiCl showed high apoptotic appearence, gaps inside spheroids due to the loss of cell interactions, severe mitochondri damage, i.e, swollen mitochondria with disrupted inner membranes, vacuoles. Some cells lost their cell membrane, consequently cell remnants can be determined in the intercellular area (Fig. 6D) . MPA in duced the loss of cell interactions, apoptotic nucleus, many auotophagic and lipid vacuoles, swollen mitochondria with disrupted and/or lost inner membranes (Fig. 6E) . No intact spheroid structure was determined in the combination of IM with MPA. High incidence of cell remnants were seen in the intercellular area. The morphological changes which were observed in rarely seen cells were listed as the loss of nucleus membranes, high apoptotic appearence, severe mitochondria damage with disrupted and/or lost outer and inner mem branes, and huge autophagic vacuoles (Fig. 6F) .
DISCUSSION
The Ishikawa human endometrial carcinoma cell line has both estrogen and progesteron receptors like type I endometrium 230 www.ejgo.org carcinoma [2] . We planned to prevent/inhibit estrogen effects by using a hormone MPA and a chemical LiCl. Both two differ ent treatments had common targets to inhibit estrogen effect. According to our results, we detected the highest efficiency in the single applied MPA and its combination with IM. Although single LiCl took third place in efficient inhibition among singly applied drugs and lost its effect much more than others as time advanced, its combination with IM was very effective and did not lose its effect in a time dependent manner.
IM was the second effective drug after MPA among the single applied drugs in the present study. As documented be fore, the mitogenic action of estrogen in the endometrial can cer through growth factors and their receptors (EGFR, IGFIR, cMET) comprise the activation of two key signaling cascades as the PI3K/AKT and the RAS/RAF/MAPK pathways. In addi tion, it was proposed that both estrogen receptor alpha (ERα) Fig. 6 . The alterations in cell ultrastructure by different drug applications. (A) Control (×7,500), (B) Imatinib mesylate (IM; ×10 k), (C) Lithium chloride (LiCl; ×6,000 and ×6,000), (D) IM+LiCl (×10 k and ×7,500), (E) Medroxyprogesterone acetate (MPA; ×7,500), (F) IM+MPA (×10 k and ×7,500). n, nucleus; nu, nucleolus; lp, lipid vacuole; mi, mitochondria; mv, microvillus; lt, lytic cytoplasm; j, junctions; v, vacuole; ch, chromatin; cr, cell remnants; *, apoptotic cell; av, autophagic vacuole; g, gaps.
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and AKT play a double role as both downstream target and activate each other. AKTmediated phosphorylation of ERα results in the transcriptional activation of ERα, independent of ligand binding [2] . IM may terminate one of the estrogen mediated mitogenic signalling through the inhibition of re ceptor tyrosine kinases in this study.
Flow cytometric apoptotic index, caspase3 levels and ultra structure analysis showed that the reason for the cell prolifera tion inhibition and the disruption of spheroid structure was apoptotic cell death. However, ultrastructure analysis of MPA and its combination with IM gave additional information that the autophagic cell death may take part in their mechanism of action. In our previous study with MPA, the FM3A murine breast tumor cell line was treated with epirubicin alone and with MPA or tamoxifen, and we determined that all drugs in duced autophagy, but when tamoxifen combined with MPA autophagy was increased [22] . Different from single MPA, autophagic vacuoles which were observed in the combintion group were huge. In contrast to our previous studies in neuro logic tumours [23] , no autophagic vacuoles were determined in the IM group. Recent reports mentioned that autophagy is a twoedged sword that can lead to cell survival or cell death (autophagic cell death). Orrenius et al. [24] suggested that there is a crosstalk between cell death modalities, and this means different signals can cause a shift from autophagy to apoptosis or apoptosis to autophagy, or a mixture of these two celldeath modes. In the light of the increased efficiency of the combination group, we suggest that autophagic vacu oles may belong to the autophagic cell death, which can exist at the same time with apoptotic cell death or can be prestep for the apoptotic cell death.
Nishio et al. [14] treated two cases of multidrugresistant re current endometrial cancer with MPA successfully. Although they accomplished complete response after surgical opera tion and post operative chemotherapy with MPA for endome trial cancer, they found lung and small intestine metastasis. Eventually, they performed surgical and postoperative therapy again. The combination of MPA with IM can treat both the pri mary tumor as endometrial cancer and metastic tumours as gastrointestinal stromal tumors (GISTs) etc. MPA can be used when the hormone receptor status are positive. In the present study, we also used LiCl without taking into consideration the estrogen and its receptor status to determine the treatment fate in MPA resistant tumours. The efficiency of LiCl with IM was also very effective in a time dependent manner similar to MPA with IM. It can be proposed that IM with LiCl can also be used effectively in MPA resistant tumours and their metastasis.
Rawnaq et al. [25] in serum of patients with GISTs and Erguven et al. [unpublished observation] in human glioblastoma cells in vitro showed that IM induced decrease in MDK levels. Con comitant with this study, in the present study we determined that IM decreased MDK levels and it was the most efficient group. Zhang et al. [20] examined the expression of the mRNA coding for seven polypeptide angiogenic factors in normal en dometrial epi thelial, stromal and three endometrial carcinoma lines. The endo metrial epithelial and stromal cells express mRNA for the poly peptide angiogenic factors, basic fibro blast growth factor, vascular endothelial cell growth factor, transforming growth factorbeta 1 and pleiotrophin, as well as the cytokine midkine. They stimulated growth of normal en dometrial epithelial cells by 17betaoestradiol and epidermal growth factor. They determined that expression of the mRNA of both vascular endo thelial growth factor and MDK in normal en dometrial epithelial cells showed a 2fold increase after treat ment with a physiological dose of 17betaoestradiol (10 10 M), while, in contrast, the mRNA of transforming growth factor beta 1 de creased 4fold after treatment with 17betaoestradi ol (10 10 M) and was abolished by exposure to progesterone (5 ×10 9 M) [21] . In our study, concomitant with Zhang et al. [20] , MPA decreased MDK levels efficiently after IM, and IM with MPA induced the highest decrease in MDK levels among all groups. As in our recent study in human neuroblastoma cell line named SHSYSY [12] , we determined that LiCl decreased MDK levels in Ishikawa human endometrium cancer cells and second highest decrease in MDK levels were determined with the combination of IM and LiCl. According to our results, it may be concluded that high MDK level decrease in combina tion groups were determined because of IMs' highest activity. We concluded that LiCl and MPA potentiated the cyctotox icity of IM, and the inhibition of estrogens activity through growth factors including MDK, wnt/catenin pathway may be involved in termination of endometrial cancer defense. This multitargeted therapies may provide treatment for resistant, metastatic and recurrent endometrial cancers with anorexia/ cachexia, physcotic disorders and contraception problems. Eventually, the treatment of cancer with/without complica tions with regained/increased life quality can be accom plished at the end of this protocol. Further investigations with different human endometrial carcinoma cell lines in vitro and in vivo are needed to start clinical trials.
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